It was reported that STC1 expression was upregulated in breast cancer, colorectal cancer, bladder cancer, and ovarian cancer, and this high expression was closely associated with the poor prognosis of cancer patients [33, 34, 35, 36]. This evidence concerns the gene STC1 and urinary bladder cancer.